Abstract
Pharmaco-resistant Epilepsy has been a major challenge for medical interventions in controlling seizures. To date, up to 33% of the patients with epilepsy do not show adequate response to anti-epileptic drugs even after prolonged combinatorial drug usage. Using microarray, this study explores the changes in hippocampal gene expression in the phenytoin-resistant pentylenetetrazol (PTZ)-kindled mouse model of epilepsy. Our results from mRNA microarray analysis show distinct gene expression profiles in the hippocampus of phenytoin-resistant and sensitive mice. Pathway enrichment analysis showed differential expression of genes involved in cholesterol biosynthesis in phenytoin-resistant and sensitive mice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data Availability
Microarray array data is being submitted to Geo data base and accession no would be provided here. Other data will be available on request.
References
Alves, M., Gomez-Villafuertes, R., Delanty, N., Farrell, M. A., O’Brien, D. F., Miras-Portugal, M. T., et al. (2017). Expression and function of the metabotropic purinergic P2Y receptor family in experimental seizure models and patients with drug-refractory epilepsy. Epilepsia, 58(9), 1603–1614. https://doi.org/10.1111/epi.13850.
Brandt, C., Bethmann, K., Gastens, A. M., & Loscher, W. (2006). The multidrug transporter hypothesis of drug resistance in epilepsy: Proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiology of Diseases, 24(1), 202–211. https://doi.org/10.1016/j.nbd.2006.06.014.
Chali, F., Djelti, F., Eugene, E., Valderrama, M., Marquer, C., Aubourg, P., et al. (2015). Inhibiting cholesterol degradation induces neuronal sclerosis and epileptic activity in mouse hippocampus. European Journal of Neuroscience, 41(10), 1345–1355. https://doi.org/10.1111/ejn.12911.
Cheng, D., Jenner, A. M., Shui, G., Cheong, W. F., Mitchell, T. W., Nealon, J. R., et al. (2011). Lipid pathway alterations in Parkinson’s disease primary visual cortex. PLoS ONE, 6(2), e17299. https://doi.org/10.1371/journal.pone.0017299.
del Toro, D., Xifro, X., Pol, A., Humbert, S., Saudou, F., Canals, J. M., et al. (2010). Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington’s disease. Journal of Neurochemistry, 115(1), 153–167. https://doi.org/10.1111/j.1471-4159.2010.06912.x.
Etminan, M., Samii, A., & Brophy, J. M. (2010). Statin use and risk of epilepsy: A nested case-control study. Neurology, 75(17), 1496–1500. https://doi.org/10.1212/WNL.0b013e3181f96253.
Karasinska, J. M., & Hayden, M. R. (2011). Cholesterol metabolism in Huntington disease. Nature Reviews Neurology, 7(10), 561–572. https://doi.org/10.1038/nrneurol.2011.132.
Khandelwal, N., Dey, S. K., Chakravarty, S., & Kumar, A. (2019). miR-30 family miRNAs mediate the effect of chronic social defeat stress on hippocampal neurogenesis in mouse depression model. Frontiers in Molecular Neuroscience, 12, 188. https://doi.org/10.3389/fnmol.2019.00188.
Kwan, P., Schachter, S. C., & Brodie, M. J. (2011). Drug-resistant epilepsy. New England Journal of Medicine, 365(10), 919–926. https://doi.org/10.1056/NEJMra1004418.
Mercado-Gomez, O. F., Cordova-Davalos, L., Garcia-Betanzo, D., Rocha, L., Alonso-Vanegas, M. A., Cienfuegos, J., et al. (2018). Overexpression of inflammatory-related and nitric oxide synthase genes in olfactory bulbs from frontal lobe epilepsy patients. Epilepsy Research, 148, 37–43. https://doi.org/10.1016/j.eplepsyres.2018.09.012.
Quintana-Pajaro, L. J., Ramos-Villegas, Y., Cortecero-Sabalza, E., Joaquim, A. F., Agrawal, A., Narvaez-Rojas, A. R., et al. (2018). The effect of statins in epilepsy: A systematic review. Journal of Neuroscience and Rural Practice, 9(4), 478–486. https://doi.org/10.4103/jnrp.jnrp_110_18.
Shao, Y., Wang, C., Hong, Z., & Chen, Y. (2016). Inhibition of p38 mitogen-activated protein kinase signaling reduces multidrug transporter activity and anti-epileptic drug resistance in refractory epileptic rats. Journal of Neurochemistry, 136(5), 1096–1105. https://doi.org/10.1111/jnc.13498.
Srivastava, N. K., Mukherjee, S., Sharma, R., Das, J., Sharma, R., Kumar, V., et al. (2019). Altered lipid metabolism in post-traumatic epileptic rat model: One proposed pathway. Molecular Biology Reports, 46(2), 1757–1773. https://doi.org/10.1007/s11033-019-04626-9.
Tang, F., Hartz, A. M. S., & Bauer, B. (2017). Drug-resistant epilepsy: Multiple hypotheses, few answers. Frontiers in Neurology, 8, 301. https://doi.org/10.3389/fneur.2017.00301.
Wang, Y., Du, X., Bin, R., Yu, S., Xia, Z., Zheng, G., et al. (2017). Genetic variants identified from epilepsy of unknown etiology in Chinese children by targeted exome sequencing. Scientific Reports, 7, 40319. https://doi.org/10.1038/srep40319.
Acknowledgements
U. A. B. and N. K. acknowledge CSIR fellowship supports for doctoral research. Mr. Jedy Jose, CCMB, Animal House was duly acknowledged for his constant support in maintaining the quality of animals used for the study.
Funding
This research was jointly supported by the Council of Scientific and Industrial Research [BSC0103-UNDO to A. K. and S. C.] and Department of Biotechnology, India [BT/PR4014/MED/30/673/2011 to A. K.].
Author information
Authors and Affiliations
Contributions
SA and UAB contributed equally to this work. SA, AK, and UAB designed the biological experiments. SA UAB, MBM, SC performed the biological experiments. UAB and AK analyzed the array data. AK supervised all of the biological experiments. UAB, SA AK, NK and SC wrote the paper, and all authors reviewed and edited their part.
Corresponding authors
Ethics declarations
Conflict of interest
There are no conflicts of interest among all authors.
Ethics Approval
We confirm that we have read the journal’s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines. Animal protocols were approved by Institutional Animal Ethics Committee (IAEC) of the CSIR- Centre for Cellular and Molecular Biology (CCMB), Hyderabad, India. The protocol was assigned the number #IAEC/CCMB/50/2018.
Consent for Publication
All authors have approved submission of this manuscript to this journal.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the Supplementary Information.
Rights and permissions
About this article
Cite this article
Amalakanti, S., Bhat, U.A., Mylavarapu, M.B. et al. Gene Expression Analysis Identifies Cholesterol Metabolism Dysregulation in Hippocampus of Phenytoin-Resistant Pentylenetetrazol-Kindled Epileptic Mice. Neuromol Med 23, 485–490 (2021). https://doi.org/10.1007/s12017-021-08648-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-021-08648-0